Shawn Hauser
USA Guide 2023
Band 4 : Cannabis Law: Western United States
Email address
[email protected]Contact number
303-860-4501Share profile
Band 4
About
Provided by Shawn Hauser
Practice Areas
- Corporate & Business
- Entheogens & Emerging Therapies
- Government & Policy
- Grants & Loans
- Hemp & Cannabinoids
Career
Shawn Hauser is a partner at Vicente LLP and co-chair of the firm's Hemp and Cannabinoids Department. She helps cannabis and hemp businesses navigate the intersections between state and federal law including hemp laws, food and drug laws, regulatory compliance, licensing, general business representation, investment, and general business matters.
Shawn advises clients on the unique legal landscape governing cannabinoids and hemp, helping them form compliant business structures, maintain compliance with hemp and food and drug laws as they evolve, and develop informed solutions that best position them for success at the state, national, and international levels.
With more than a decade of experience in cannabis law and policy, Shawn is a go-to source for businesses, industry groups, governments, and reporters seeking opinions, analysis, and guidance on cannabis and hemp law and policy matters.
Professional Memberships
- International Cannabis Bar Association
- Regulatory Affairs Committee, Council for Responsible Nutrition
- Steering Committee, American Hemp Campaign
- Legislative Review Committee, Hemp Industries Association
- Cannabis Committee & Education Committee, American Herbal Products Association
- Local Government Implementation Team, Sensible Colorado
Publications
Co-author, "Is Minnesota’s New Hemp-derived THC Edible Law Discriminatory?" October 19, 2022
Co-author, "Lessons Learned from the Regulation of CBD Products in the United Kingdom," Sept 20, 2022
Co-author, "Key Takeaways from Intoxicating Cannabinoids: The Science and the Law Webinar," June 16, 2022
Author, "Clearing the Air: Vicente Sederberg's Position on Intoxicating Hemp Products," May 17, 2022
Co-author, "FDA Enforcement Action Targeted at Hemp-Derived Delta-8 Products," May 5, 2022
Articles, highlights and press releases
4 items provided by Vicente LLP
Vicente LLP Expands Hemp Product Compliance Resources with New Hemp Cannabinoid Legality Guide
Navigating the ever-changing legal landscape of hemp products across 50 states can be confusing and costly, and staying informed with the latest hemp laws, litigation, and enforcement activities can be overwhelming. Vicente LLP offers ease and support with the launch of its new guide.
DEA Moves to Reclassify Marijuana from Schedule I to Schedule III, Marking Historic Shift in U.S. Dr
It was reported Tuesday that the U.S. Drug Enforcement Administration will reclassify cannabis from Schedule I to Schedule III, per the August recommendation from the U.S. Department of Health and Human Services.
4 Major Implications of Cannabis Moving to Schedule III
After 50 years of being in the most restrictive schedule alongside drugs like heroin and PCP, the DEA will move to reschedule marijuana from Schedule I to Schedule III, where the plant’s medical benefits will finally be recognized by the federal government.
Best Lawyers® Recognizes 18 Attorneys From Cannabis and Psychedelics Law Firm Vicente LLP
Eighteen attorneys from cannabis and psychedelics law firm Vicente LLP were recognized in the 30th edition of The Best Lawyers in America®
Vicente LLP Expands Hemp Product Compliance Resources with New Hemp Cannabinoid Legality Guide
Navigating the ever-changing legal landscape of hemp products across 50 states can be confusing and costly, and staying informed with the latest hemp laws, litigation, and enforcement activities can be overwhelming. Vicente LLP offers ease and support with the launch of its new guide.
DEA Moves to Reclassify Marijuana from Schedule I to Schedule III, Marking Historic Shift in U.S. Dr
It was reported Tuesday that the U.S. Drug Enforcement Administration will reclassify cannabis from Schedule I to Schedule III, per the August recommendation from the U.S. Department of Health and Human Services.
4 Major Implications of Cannabis Moving to Schedule III
After 50 years of being in the most restrictive schedule alongside drugs like heroin and PCP, the DEA will move to reschedule marijuana from Schedule I to Schedule III, where the plant’s medical benefits will finally be recognized by the federal government.
Best Lawyers® Recognizes 18 Attorneys From Cannabis and Psychedelics Law Firm Vicente LLP
Eighteen attorneys from cannabis and psychedelics law firm Vicente LLP were recognized in the 30th edition of The Best Lawyers in America®